Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.
Lenard A. Adler, M.D.; David W. Goodman, M.D.; Scott H. Kollins, Ph.D.; Richard H. Weisler, M.D.; Suma Krishnan, M.S.; Yuxin Zhang, Ph.D.; and Joseph Biederman, M.D., on behalf of the 303 Study Group. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Published online ahead of print. J Clin Psychiatry September 9, 2008: e1–e10 (pii: ej08m04166). Available at PSYCHIATRIST.COM © Copyright 2008 Physicians Postgraduate Press, Inc
